Long QT Syndrome surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Long QT Syndrome}}
{{Long QT Syndrome}}
 
{{CMG}} {{AE}} {{F.K}}


==Overview==
==Overview==
Surgical intervention is not recommended for the management of [disease name].
[[Surgery]] is usually reserved for patients with either Strong family history of [[sudden cardiac death]] OR high-risk patients with [[Jervell Lange-Nielsen syndrome|Jervell]] and Lang-Nielsen syndrome.
 
OR
 
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
 
OR
 
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
 
OR
 
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
 
OR
 
Surgery is the mainstay of treatment for [disease or malignancy].


==Indications==
==Indications==
*[[Implantable cardioverter defibrillator|Implantable cardioverter-defibrillator]] is not the first-line treatment option for patients with long QT syndrome. Surgery is usually reserved for patients with either:<ref name="pmid12741701">{{cite journal |vauthors=Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M |title=Implantable cardioverter defibrillator in high-risk long QT syndrome patients |journal=J. Cardiovasc. Electrophysiol. |volume=14 |issue=4 |pages=337–41 |date=April 2003 |pmid=12741701 |doi=10.1046/j.1540-8167.2003.02545.x |url=}}</ref><ref name="pmid18549912">{{cite journal |vauthors=Goldenberg I, Moss AJ |title=Long QT syndrome |journal=J. Am. Coll. Cardiol. |volume=51 |issue=24 |pages=2291–300 |date=June 2008 |pmid=18549912 |doi=10.1016/j.jacc.2008.02.068 |url=}}</ref>
**Strong family history of sudden cardiac death
**High-risk patients with [[Jervell and Lange-Nielsen syndrome|Jervell]] and Lang-Nielsen (JLN) syndrome


*Surgical intervention is not recommended for the management of [disease name].
*Left cervicothoracic stellectomy is another [[antiadrenergic]] therapeutic measure used in high-risk patients with long QT syndrome (LQTS), especially in those with recurrent cardiac events despite [[beta-blocker therapy]].
OR
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
**[Indication 1]  
**[Indication 2]
**[Indication 3]
 
==Surgery==
 
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
*Surgery is the mainstay of treatment for [disease or malignancy].


==Contraindications==
==References==
==References==



Latest revision as of 16:13, 16 April 2020

Long QT Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Long QT Syndrome from other Diseases

Epidemiology and Demographics

Risk Stratification

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Genetic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Long QT Syndrome surgery On the Web

Most recent articles

Most cited articles

Review articles

Programs

slides

[1]

American Roentgen Ray Society Images of Long QT Syndrome surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

on Long QT Syndrome surgery

CDC onLong QT Syndrome surgery

QT Syndrome surgery in the news

on Long QT Syndrome surgery

Directions to Hospitals Treating Long QT Syndrome

Risk calculators and risk factors for Long QT Syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Farima Kahe M.D. [3]

Overview

Surgery is usually reserved for patients with either Strong family history of sudden cardiac death OR high-risk patients with Jervell and Lang-Nielsen syndrome.

Indications

  • Implantable cardioverter-defibrillator is not the first-line treatment option for patients with long QT syndrome. Surgery is usually reserved for patients with either:[1][2]
    • Strong family history of sudden cardiac death
    • High-risk patients with Jervell and Lang-Nielsen (JLN) syndrome
  • Left cervicothoracic stellectomy is another antiadrenergic therapeutic measure used in high-risk patients with long QT syndrome (LQTS), especially in those with recurrent cardiac events despite beta-blocker therapy.

References

  1. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M (April 2003). "Implantable cardioverter defibrillator in high-risk long QT syndrome patients". J. Cardiovasc. Electrophysiol. 14 (4): 337–41. doi:10.1046/j.1540-8167.2003.02545.x. PMID 12741701.
  2. Goldenberg I, Moss AJ (June 2008). "Long QT syndrome". J. Am. Coll. Cardiol. 51 (24): 2291–300. doi:10.1016/j.jacc.2008.02.068. PMID 18549912.